Federal Register notice: FDA sends to OMB an information collection extension entitled Prescription Drug Advertising--21 CFR Part 202.
Federal Register notice: FDA sends to OMB an information collection extension entitled Medical Product Communications That Are Consistent With the FDA...
Federal Register notice: FDA announces the generic animal user fee rates and payment procedures for fiscal year 2022.
Greenleaf Health adds former FDAers Julia Barrett, Chris Leptak, and Grace McNally to its regulatory consulting staff.
FDA says it will not meet the already-extended PDUFA action dates for Pfizer submissions for abrocitinib and Xeljanz.
FDA says it is soliciting applications for new Patient Engagement Collaborative members.
FDA grants full approval to the combination of Mercks Keytruda and Eisais Lenvima for treating certain patients with advanced endometrial carcinoma.
An Annenberg Public Policy Center poll shows that the degree of confidence in FDA respondents have varies with their primary source of media.